scispace - formally typeset
C

Cathy Mojzisik

Researcher at Ohio State University

Publications -  43
Citations -  1841

Cathy Mojzisik is an academic researcher from Ohio State University. The author has contributed to research in topics: Radioimmunoguided surgery & Colorectal cancer. The author has an hindex of 21, co-authored 43 publications receiving 1812 citations. Previous affiliations of Cathy Mojzisik include James Cancer Hospital.

Papers
More filters
Journal ArticleDOI

Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long‐term survival

TL;DR: It is postulate that patients with Dukes' B colon cancer who die of their disease have occult micrometastases in their pericolic lymph nodes at the time of original diagnosis.
Journal ArticleDOI

A comprehensive overview of radioguided surgery using gamma detection probe technology

TL;DR: In the current review, this work has attempted to comprehensively evaluate the history, technical aspects, and clinical applications of radioguided surgery using gamma detection probe technology.
Journal ArticleDOI

Radioimmunoguided surgery using monoclonal antibody.

TL;DR: Improved selection of patients for antigen-positive tumors, the use of higher affinity second-generation antibodies, alternate routes of antibody administration, alternate radionuclides, and more sophisticatedly bioengineered antibodies and antibody combinations should all lead to improvements in radioimmunoguided surgery.
Journal ArticleDOI

Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors

TL;DR: The authors have developed a hand-held gamma-detecting probe (GDP) for intraoperative use that improves the sensitivity of external radioimmunodetection and may influence the short-term morbidity and mortality of surgery for colorectal cancer.
Journal ArticleDOI

Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody.

TL;DR: Radioimmunoguidcd surgery with CC49 provides useful, immediate intraoperativc information not available by other techniques, and alters the planned operative procedure.